Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$863,523
-$89,940 QoQ
Shares Held
7,305
-3.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 56.591375770020534.ToString("F0")%
Shared 0.ToString("F0")%
None 43.408624229979466.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FRED ALGER MANAGEMENT, LLC holds $17,745,861 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
136,254 | $10,334,865 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,522 | $2,681,455 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
81,865 | $2,465,773 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
123,961 | $1,180,108 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
7,305 | $863,523 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,671 | $220,137 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $863,523 | 7,305 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $953,463 | 7,578 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,122,127 | 7,669 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,245,727 | 7,988 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $570,676 | 3,466 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $595,020 | 3,652 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $776,244 | 3,973 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $688,759 | 3,973 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $758,737 | 4,484 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $885,007 | 4,484 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,980,240 | 11,382 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $772,189 | 4,484 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,567,945 | 27,445 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $657,130 | 4,484 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $664,932 | 4,484 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $770,754 | 4,484 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $926,731 | 4,914 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,088,444 | 41,341 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $76,179,565 | 392,395 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $90,343,228 | 484,778 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $31,787,338 | 201,850 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $76,008,026 | 459,263 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $69,039,659 | 417,486 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,806,483 | 56,965 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $32,094,886 | 272,707 | Shares | Sole | 2020-05-19 | |
| No filing history on record for this holder in this stock. | ||||||